Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

D.C. Court of Appeals Strengthens IRS’ Ability to Collect Penalties for Not Reporting Foreign Company Ownership

Janine Anthony Bowen Delivers Remarks at GSU College of Law 2024 Honors Day Ceremony

Jonathan Forman Serves as Instructor for Seminar on Designing and Implementing an Information Security Program

BakerHostetler’s IncuBaker team recognized by International Legal Technology Association’s Distinguished Peer Awards

The Supreme Court seemed, at least to a small degree, interested in evaluating the subject matter eligibility of diagnostic claims when it requested that the respondents (Natera Inc. and Eurofins Viracor Inc.) respond to a petition for writ of certiorari filed by CareDx Inc. and the Board of Trustees of the Leland Stanford Junior University (collectively “CareDx”). CareDx had asked the Court to address the following <a href="/blogs/will-the-supreme-court-reevaluate-the-subject-matter-eligibility-of-diagnostic-claims/">question</a>:

core/paragraph


<p style="padding-left: 40px;">Congress has provided that any “new and useful process” is eligible for patent protection, and that “any new and useful improvement thereof” is also eligible for patent protection. 35 U.S.C. 101. The question presented is whether a new and useful method for measuring a natural phenomenon, that improves upon prior methods for measuring that very same phenomenon, is eligible for patent protection under Section 101.</p>

core/freeform

But the Court denied CareDx’s petition, continuing its trend of refusing to reevaluate subject matter eligibility in the life sciences space and beyond. From the Order List issued by the Court on Oct. 2, we at least know that Justice Brett Kavanaugh would have granted the petition. Once again, we wait for another case to be brought to the Court or for Congress to act.

The Supreme Court Again Declines To Reevaluate Subject Matter Eligibility of Diagnostic Claims

Featured Insights

Related Services

Featured Insights